Return to homepagePandemic Pact

GLYCOVID-19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $478,800

  • Funder

    Novo Nordisk Foundation

  • Principal Investigator

    N/A

  • Research Location

    Denmark

  • Lead Research Institution

    Steno Diabetes Center Copenhagen, Herlev & Gentofte Hospital and Hvidovre Hospital

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The project will investigate how COVID-19 affects the heart's pumping function and the blood's coagulation ability at various blood glucose levels. Studies have shown that one third of the patients who die from COVID-19 also suffer from diabetes. Changing the monitoring of glucose levels during intensive care can potentially have a negative effect on the heart's function, especially in patients with high glucose levels prior to their admission. The project will examine diabetes patients as well as COVID-19 positive patients, both with and without diabetes, during the first 24 hours of their admission to intensive care. In addition, as many participants as possible will be examined four weeks after the emergency care has ended.